4-(3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide,
deracoxib,
Deracoxib,
169590-41-4,
Deramaxx,
4-(3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide,
SC 46,
SC 046,
SC 59046,
Deram,
UNII-VX29JB5XWV,
SC-59046,
VX29JB5XWV,
CHEMBL28636,
4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide,
C17H14F3N3O3S,
CHEBI:73032,
NCGC00095312-01,
AK-60962,
DSSTox_CID_25975,
DSSTox_RID_81266,
DSSTox_GSID_45975,
4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamide,
CAS-169590-41-4,
Deracoxib [USAN:INN],
deracoxibum,
Deracoxib (USAN),
Spectrum2_000521,
Spectrum3_001677,
Spectrum4_001227,
Spectrum5_001644,
AC1MHW65,
SCHEMBL24645,
BSPBio_003493,
KBioGR_001694,
SPBio_000501,
DTXSID4045975,
KBio3_002713,
EX-A887,
HMS2093M12,
Pharmakon1600-01505222,
ZINC607803,
BCP04295,
KS-00000G0A,
Tox21_111503,
BDBM50057583,
CCG-39562,
MFCD09837763,
NSC758935,
SC-046,
AKOS016009604,
Tox21_111503_1,
API0019295,
BCP9000598,
CS-2107,
NSC-758935,
NCGC00095312-02,
NCGC00095312-04,
4CA-0448,
AJ-23690,
AS-19558,
HY-17509,
BCP0726000080,
SBI-0206729.P001,
AB0035926,
AX8123794,
FT-0665858,
ST24042879,
Y0377,
D03689,
AB01563051_01,
SR-05000001985,
J-010565,
SR-05000001985-1,
BRD-K68558722-001-02-4,
4-[3-Difluoromethyl-5-(3-fluoro-4-methoxy-phenyl)-pyrazol-1-yl]-benzenesulfonamide,
4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide,
Benzenesulfonamide, 4-(3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)-,
Deracoxib [USAN],
ACN-029036,
CID3058754,
CS-W-00227,
C17-H14-F3-N3-O3-S,
B1091,
Benzenesulfonamide, 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-,